Lineage Cell Therapeutics updates COR1 corneal cell therapy program

Go back to Lineage Cell Therapeutics updates COR1 corneal cell therapy program
(NYSE: LCTX) Delayed: 1.03 -0.04 (3.74%)
Previous Close $1.07    52 Week High
Open $1.10    52 Week Low
Day High $1.10    P/E N/A 
Day Low $1.03    EPS
Volume 901,701